CHICAGO, Feb. 27, 2018 -- AllSpire Health GPO, LLC—a health system alliance created to escalate the improvement of clinical outcomes, enable greater access to affordable healthcare, ensure economic sustainability, and enhance patient, physician, and clinician satisfaction—announced a partnership with Lumere today. AllSpire will implement the company’s Category Optimization and Product Introduction Management solutions as part of its ongoing initiatives to optimize the value its members provide to patients.
“Lumere’s clinical approach to managing medical device selection and utilization aligns with AllSpire’s mission to drive comprehensive clinical excellence to the communities our member hospitals serve,” said AllSpire Executive Director Michael Dankwerth. “Collaboration with physicians is fundamental to driving change, and Lumere’s recommendations take a clinical evidence-based and patient-first approach to uncovering saving opportunities. As a result, we can ensure that clinical and administrative leaders are making informed decisions about what’s best for our patients based on information presented in a language they all understand.”
According to Lumere CEO Hani Elias, JD, MPH, the company is honored to enable AllSpire’s efforts to improve affordability and outcomes across its membership, which includes nearly 40 acute care facilities in multiple states. “AllSpire is committed to taking an innovative approach to address unnecessary utilization of medical devices, which contributes to significant waste in the healthcare system,” he said. “We are equally committed to providing leading-edge solutions that address the root causes of variation and cost inflation.”
Dankwerth said that Lumere’s combination of proprietary research, algorithms and data modeling will fundamentally impact what AllSpire can achieve in terms of medical product pricing and utilization strategies. “By comparing clinically and functionally similar products and looking for variation across our member facilities, we’ll be able to undercover and act on significant opportunities that wouldn’t have been visible to us otherwise,” he said. “Lumere provides a direct comparison of products based on evidence, outcomes and technologies. This leads to clinically integrated decisions regarding sourcing strategies and vendor negotiation tactics, along with key insights to support clinical decision making, enhance outcomes and realize savings.”
About AllSpire Health GPO, LLC
Founded in 2016, AllSpire Health GPO, LLC is a collaborative, regional group purchasing organization utilizing innovation as a platform to escalate the improvement of clinical outcomes, enable greater access to affordable healthcare, ensure economic sustainability, and enhance patient, physician, and clinician satisfaction amongst its members. AllSpire delivers value via the development and execution of clinical and service line improvement initiatives across the care continuum.
AllSpire has five founding members: Atlantic Health System, Morristown NJ; Lehigh Valley Health Network, Allentown PA; Hackensack Meridian Health, Edison NJ; Tower Health, Reading PA; and WellSpan Health, York PA. Currently representing 38 acute care facilities and over 1,400 non-acute facilities, AllSpire operates in the Northeast and Mid-Atlantic United States. For more information, please visit www.allspirehealthpartners.org.
About Lumere
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit Lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.
| Media Contacts | |
| Pam Flores | Michael Dankwerth |
| [email protected] | [email protected] |
| (773) 218-9260 | (484) 661-5918 |


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 



